HIV Flashcards
HIV1 vs HIV2
HIV-1- more prevelant in the U.S and more pathogenic (rapid progression to AIDS)
HIV-2- more in Western Africa, less pathogenic, more resistant to NNRTs
Souce of Transmission: body fluids of infected person
Cell surface receptors for HIV
CD4
CCR5
HIV testint
Seroconversion window period
- time of infection to production of antibodies
- average 3-4 weeks but up to 6 months
- acute HIV
HIV tetsing
- Rapid (antibody test)- bllod or oral fluid, rapid test requires confirmation if reactive
- Combination immunotherapy (4th gen)- HIV-1 or HIV-2 antibodies and HIV-1 protein 24, more sensetive to early detection
- PCR test- viral load test detects genetic material of HIV
Emtriva (emtricitabine, FTC)
NRTI
Headache, GI intolerance, rash
Emtricitabine used for HIV and HBV
Rare hyperpigmentaition of palms and soles of feet more with African Americans
Epivir (lamivudine, 3TC)
NRTI
Headache, GI intolerance, rash
Can be used in HBV infections
Viread (tenofovir disoproxil fumarate or TDF)
NRTI
GI intolerance (fatulence and diarrhea), headache,
decreased bone marrow density, osteomalacia, renal impairment (TDF), Fanconi Syndrome
TDF associated with lower lipid levels (good patients with hyperlipidemia)
Used to treat HBV too
Vemlidy (tenofovir alafenamide, TAF)
- NRTI
- Higher lipid levels but better for the kidneys
- substrate of p- glycoprotein- DDI will lower the TAF levels (subtheraputic)
- Phenytoin, oxcarbazepine, phenobarbital, rifampin, rifabutin, rifapentine, St. John’s Worts
- Used to treat HBV too
Ziagen (abacavir, ABC)
NRTI
Liver metabolism via alcohol dehydrogenase- caution in hepatic impairment and alocholics
Hypersenitivity reactions- check HLA-B*5702 test
- Positive then avoid the drug and report as allergy on patient chart
- Even if the test is negative report signs and symptoms if they develop
Increased risk of MI
Travada (emtricitabine/ tenofovir disoproxil furarate, FTC/ TDF)
NRTI
Can be used as prophylaxis too
Descovy (emtricitabine/ tenofovir alafenamide, FTC/TAF)
NRTI
For HIV and HBV
Epzicom (lamivudine/ abacavir, 3TC/ABC)
NRTI
Generally what is the MOA of NRTIs and drug class side effects?
Pharmacokinetics?
MOA- inhibit HIV-1 reverse transciptase (RT) by competitive inhibition of the enzyme as well as chain termination
- drug binds to RT instead of virus
ADR- lactic acidoisis and hetaptic steatosis, lipodystrophy/ lipoatrophy (more common with stavudine)
Pharmacokinitics- mostly renally excreted except Ziagen (abacavir)- liver metabolism via ADH
Which NRTI can be used to treat HBV?
Emtriva (emtricitabine)
Epivir (lamivudine)
Viread (tenofovir disoproxil fumarate, TDF)
Vemlidy (tenofovir alafenamide, TAF)
Pifeltro (doravirine)
NNRT
LEAST CNS TOXICITY IN CLASS
Nausea, diarrhea, abdominal pain, dizsiness, headache, fatigue, abnormal dreams
Edurant (rilpivirine, RPV)
NNRT
A bit more CNS effetcs then doravirine
Depression, insomnia, headache, rash
Take with food (need acidic environment for absportion)
Contraindicated with PPIs
Take H2 anatagonist at least 12 hours before or 4 hours after rilpivirine
Take anatacids 2 hours before or 4 hours after rilpivirine
Sustiva (efavirenz, EFV)
NNRTI
MOST CNS EFFECTS
dizziness, drowsiness, sleepiness, insomnia, vivid dreams
Lipophilic drug so take on an empty stomach _(_food would cause increase CNS effects)
CYP2B6 substrate induction pathway- genetic polymorphism may lower the metabolism (increased ADR)
- give lower dose efavirenz in symfi Lo may be better tolerated
Neural tube defects in first trimester of pregnancy
Decreases levels of rifampin, rifabutin, voriconazole, methoaone, statin
Delstrigo (doravirine/ lamivudine/ TDF)
NNRTI/ NRTI/ NRTI
Complera (rilpivirine/ emtricitabine/ TDF)
NNRTI/ NRTI/ NRTI
Rilpivirine
- Contraindicated with PPIs
- Take H2 anatagonist at least 12 hours before or 4 hours after rilpivirine
- Take anatacids 2 hours before or 4 hours after rilpivirine
Odefsey( rilpivirine/ emtricitabine/ TAF)
NNRTI/ NRTI/ NRTI
Rilpivirine
- Contraindicated with PPIs
- Take H2 anatagonist at least 12 hours before or 4 hours after rilpivirine
- Take anatacids 2 hours before or 4 hours after rilpivirine
Atripla (efavirenz/ emtricitabine/ TDF)
NNRTI/ NRTI/ NRTI
What is the MOA of NNRTI and drug class side effects?
- MOA- inhibits RT by directly binding to it (non-competitve inhibition of RT)
-
ADR
- Toxic epidermal necrolysis (TEN)
- Stevens- Johnson Syndrome (SJS)
- Liver toxicity
-
NNRTI levels decrease with
- rifampin, carbamazepine and phenytoin
- CYP 3A4 inducer
- Kinietics- liver elimination
Prevista (darunavir)
Protease Inhibitors
600 mg tablet + Norvir (ritonavir)- for pregnant women
800 mg tablet+ norvir (ritonavir) or cobicistate- everyone else
Possible skin reaction due to sulfonamide
Potenial CV risk
Norvir (ritonavir)
Protease Inhibitior
but used as PK booster
Reyataz (atazanavir)
Protease Inhibitor
Hyperbilirubinemia and nephrolithiasis
Interactions with acid sepressive therapy (no PPI and spacing with H2 blockers, and antacids)
Symtuza (darunavir/ cobicistat/ emtricitabine/ TAF)
Protase inhibitor/ PK booster/ NRTI/ NRTI
Prezocobix (darunavir/ cobicistat)
Protase Inhibitor/ PK booster
NOT for pregnant women combined formulation only comes with darunavir 800 mg
Evotaz (atazanavir/ cobicistate)
Protease inhibitor and PK booster
Atazanavir- Interactions with acid sepressive therapy (no PPI and spacing with H2 blockers, and antacids)
What is the MOA of protease inhibitors? class side effects? Pharmacokinites?DDI?
MOA- inhibit HIV protease to prevent cleavage of proteins, resulting in no active proteins
ADR- GI intolerance, Hyperlipidemia, CV risk, blood glucoase elevation, liver toxicity, possible bleeding risk in hemophiliacs, body fat re-distribution (lipodystrophy)
PK- Liver metabolism
CYP 450 and P-gp- cyp inhibitor- statins, fluticasone, salmeterol, rifampin, hep c antiviral, anticoagulant, certain antifungals, quetiapinem st, johns worts
Isentress (raltegravir)
Integrase Inhibitor
Pg-P substrate
Trivicay (dolutegravir)
Integrase Inhibitor
ADR- Neuropsychiatric effects (insomnia, depression, etc. do not use if there is underlaying psych condition), nural tube defects (avoid in women of childbearing age not on contreception or within12 weeks post conception
Metformin interactions- increase metformine levels (1000mg daily max)- increases diarrhea
Virekta( elvitegravir)
Integrase inhibitor
Take with food
Biktarvy (emtricitabine/ TAF/ Bictegravir)
NRTI/ NRTI/ INTI
Bictegravir-increases metformin levels but done need to adjust dose just monitor
Genvoya (emtricitabine/ TAF/ elvitegravir/ cobicistat)
NRTI/NRTI/ INSTI/PK
-
Elvitegravir
- Take with food- less GI effects
-
Cobicistat
- nausea, diarrhea, lipid abnormalitiesand glucose elevation
Stribild (emtricitabine/ TDF/ Elvitegravir/ cobicistat)
NRTI/ NRTI/ INSTI/ PK
-
Elvitegravir
- Take with food- less GI effects
-
Cobicistat
- nausea, diarrhea, renal impairment, decrease bone mineral density
Triumeq (lamivudine/ abacavir/ dolutegravir)
NRTI/ NRTI/ INSTI
MOA if intergrase inhibitors? class side effects? metabolism? DDI?
MOA- inhibit integrase, prevent integration of viral DNA into human DNA
ADR- Insomnia, headache, possible weight gain, increase in liver enzymes and creatine kinase (CK)
Metabolism- UGT1A1
DDI- calcium or iron supplements, cation containing antacids or laxatives, sucralfate, buffered metabolism (spacing from INSTI)
DDI- Rifampin, carbamazepine, phenytonin, St. Johns Worts (reduce plasma levels of integrase inhibitors)
Juluca (rilpiverine/ Dolutegravir)
NNRTI/ INSTI
must have undetectable viral load
Rilpivirine effects- has to be taken with food,
- Contriindicated with PPIs, defetilide
- interactions with antacids, H2 blockers
Dolutegravir
- interactins between metformin and rifampin
Tybost (cobicistat)
PK booster
inhibitor of CYP 3A4
Sekzentry (maraviroc)
CCR5 inhibitor
must have CCR5 receptor- CCR5 tropism test
Treatemt for HIV resistance+ added to therapy
Side effects- LIVER TOXICITY- BLACK BOX WARNING
METABOLISM- CYP 3A4 and P-gp
Fuzeon (enfuvirtide)
Infusion infections
only injectable part of HIV regimen
inhibits function of transmembrane gp 41
No significant DDI
Trogarzo (ibalizumab)
Post attachment inhibitor
Recombinant monoclonal antibodies
binds to host CD4 cell and interfers with post-attachment steps
Used for HIV resistance or people born with HIV
Administered IV- loading dose, followed by maintenance dose every 2 weeks